期刊文献+

临床药师对难治性嗜麦芽窄食单胞菌脓毒血症患儿的药学监护 被引量:1

Pharmaceutical Care for a Child with Refractory Stenotrophomonas maltophilia Sepsis by Clinical Pharmacist
下载PDF
导出
摘要 目的:探讨临床药师在儿童难治性嗜麦芽窄食单胞菌脓毒血症治疗中的药学监护,为该病患儿的治疗提供参考。方法:临床药师参与难治性嗜麦芽窄食单胞菌脓毒血症患儿的诊疗过程。根据患儿的病理生理特点及抗菌药物的药动学/药效学特性,临床药师建议抗感染方案调整为头孢哌酮钠舒巴坦钠160 mg/(kg·d),每8 h给药1次+左氧氟沙星10 mg/kg,每12 h给药1次;针对患儿全身炎症反应重的临床表现,临床药师建议加用甲泼尼龙琥珀酸钠1 mg/kg,每12 h给药1次抗炎辅助治疗;同时,临床药师在整个治疗过程中对患儿进行个体化用药监护(包括头孢哌酮钠舒巴坦钠血药浓度监测、不良反应监测以及氧气雾化给药教育等),并对患儿随访1年。结果:医师采纳临床药师的建议。患儿的脓毒血症得以控制,病情好转予以出院;随访中患儿未出现软骨及关节损伤等不良反应。结论:免疫力低下、入住重症监护病房时间长、气管插管、恶性肿瘤等是嗜麦芽窄食单胞菌感染的高危因素。头孢哌酮钠舒巴坦钠的治疗药物监测在儿童重症感染治疗中非常必要,权衡利弊、满足一定条件后,儿童可以使用喹诺酮类抗菌药物抗感染;在有效的抗感染治疗下,小剂量糖皮质激素可减轻脓毒血症患儿全身炎症反应。 OBJECTIVE:To investigate the pharmaceutical care for a child with refractory Stenotrophomonas maltophilia sepsis by clinical pharmacists,and to provide reference for the treatment of children with this disease.METHODS:Clinical pharmacist participated in drug therapy for a child with refractory S.maltophilia sepsis.Based on the pathophysiological characteristics of the child and the PK/PD characteristics of the antimicrobials,clinical pharmacists suggested that the anti-infection regimen should be adjusted as cefoperazone sodium and sulbactam sodium 160 mg/(kg·d),every 8 hours combined with levofloxacin 10 mg/kg,every 12 hours.For clinical manifestations of severe inflammatory reaction,the clinical pharmacist suggested receiving methylprednisolone sodium succinate 1 mg/kg additionally,every 12 hours,for anti-inflammatory adjuvant therapy.At the same time,clinical pharmacist provided individualized pharmaceutical care(including the detection of blood concentration of cefoperazone sodium and sulbactam sodium,the detection of ADR and medication education of oxygen atomization)during the treatment,and followed up the child for one year.RESULTS:The doctors adopted the suggestions of clinical pharmacists.The sepsis was controlled,the child’s condition were improved and then discharged.During the follow-up,the child did not suffered from ADR,such as cartilage and joint injury.CONCLUSIONS:Hypoimmunity,long stay in intensive care unit,endotracheal intubation and malignant tumor are the high risk factors of S.maltophilia infection.The monitoring of therapeutic drugs of cefoperazone sodium and sulbactam sodium is very necessary in the treatment of severe infection in children.After weighing the advantages and disadvantages and meeting certain conditions,children can use quinolones for anti-infection;based on the effective anti-infection treatment,low-dose glucocorticoid can reduce the systemic inflammatory respense in patients with sepsis.
作者 陈辞 李卓 阳波 王胜峰 CHEN Ci;LI Zhuo;YANG Bo;WANG Shengfeng(Hengyang Medical School,University of South China/Dept.of Pharmacy,the First Affiliated Hospital of University of South China,Hunan Hengyang 421001,China;Dept.of Pharmacy,the Third Xiangya Hospital of Central South University,Changsha 410013,China)
出处 《中国药房》 CAS 北大核心 2021年第23期2911-2916,共6页 China Pharmacy
基金 衡阳市科技计划项目(No.2020jh042756) 湖南省医学会医学科研基金-临床药学项目(No.HMA202001011)。
关键词 儿童 难治性 嗜麦芽窄食单胞菌 脓毒血症 药学监护 Children Refractory Stenotrophomonas maltophilia Sepsis Pharmaceutical care
  • 相关文献

参考文献8

二级参考文献48

  • 1潘计调,陈剑平,郭来洲.嗜麦芽窄食假单孢菌致肺炎伴急性骨髓炎1例[J].中国实用医药,2007,2(14). 被引量:1
  • 2戴新建,郑永克,郑纪阳,陈身贤.嗜麦芽窄食单胞菌医院获得性肺炎危险因素的探讨[J].浙江医学,2006,28(5):392-394. 被引量:1
  • 3汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:285
  • 4刘双全,匡艳华,王巍巍,等.头孢哌酮/舒巴坦对非发酵革兰阴性杆菌的抗菌活性[J].中华医院感染学杂志,2011,19(20):3091-3093.
  • 5汪复.2006年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(1):1-9. 被引量:281
  • 6Cai JC,Zhon Hw,Zhang R,et al.Emergence of Serratiamarcescens,Klebsiella pneumoniae,and Escherichia coli iso-lates possessing the plasmid-mediated carbapenem-hydroly-zing beta-lactamase KPC-2in intensive care units of a Chinesehospital[J].Antimicrob Agents Chemother,2008,52(6):2014-2018.
  • 7Marchahn D,Navon-Venezia S,Schwaber MJ,et al.Isolationof imipenem-resistant Enterobacter species:emergence ofKPC-2carbapenemase,molecular characterization,epidemiol-ogy,and outcomes[J].Antimicrob Agents Chemother,2008,52(4):1413-1418.
  • 8Lob SH,Badal RE,Bouchillon SK,[et al].Epidemiology and suscep-tibility of gram-negative appendicitis pathogens:SMART 2008-2010[J].Surg Infect(Larchmt),2013,14(2):203-208.
  • 9Poudyal N,Gyawali N,Gurung R,et al.In vitro activity ofcefoperazone-sulbactam combination against gram negative ba-cilli[J].Nepal Med Coll J,2012;14(1):5-8.
  • 10Pei G,Mao Y,Sun Y.In vitro activity of minocycline aloneand in combination with cefoperazone-sulbactam against car-bapenem-resistant Acinetobacter baumannii [J].Microb DrugResist,2012,18(6):574-577.

共引文献529

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部